Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400095085Phase 4Not yet recruiting
Phase 4 trial of oliceridine in vertebral compression fracture (VCF) (3 arms), sponsored by Ningde Mindong Hospital. Primary endpoint: Pain VAS score. Planned start Dec 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400095085.